Increase in Pneumococcus Macrolide Resistance, United States

by Stephen G. Jenkins, David J. Farrell
Published 2009-08-01

Design, synthesis and evaluation of novel 2,2-dimethyl-2,3-dihydroquinolin-4(1H)-one based chalcones as cytotoxic agents

by Julie Jean, David S. Farrell, Angela M. Farrelly, Sinead Toomey, James W. Barlow
Published 2018-09-01

Emergence and Spread of Streptococcus pneumoniae with erm(B) and mef(A) Resistance

by David J. Farrell, Stephen G. Jenkins, Steven D. Brown, Manish Patel, Bruce S. Lavin, Keith P. Klugman
Published 2005-06-01

Klebsiella pneumoniae Carbapenemase, Canada

by Dylan R. Pillai, Roberto G. Melano, Prasad Rawte, Stephen Lo, Nathalie Tijet, Milan Fuksa, Nancy Roda, David J. Farrell, Sigmund Krajden
Published 2009-05-01

Macrolide-Resistant Mycoplasma pneumoniae in Humans, Ontario, Canada, 2010–2011

by AliReza Eshaghi, Nader Memari, Patrick Tang, Romy Olsha, David J. Farrell, Donald E. Low, Jonathan B. Gubbay, Samir N. Patel
Published 2013-09-01

Respiratory Infection in Institutions during Early Stages of Pandemic (H1N1) 2009, Canada

by Alex Marchand-Austin, David J. Farrell, Frances B. Jamieson, Nino Lombardi, Ernesto Lombos, Sunita Narang, Holy Akwar, Donald E. Low, Jonathan B. Gubbay
Published 2009-12-01

End-game : why American interventions become quagmires

by Kolenda, Christopher David
Published 2017